[1]
G. A. Parra Serrano, M. P. Torres Langhammer, A. J. Pinto Arias, and S. Serrano-Gómez, “Effectiveness of IDegLira in Type-2 Diabetes Patients During the COVID-19 Pandemic: A Teleconsultation Follow-up”, Rev.ACE, vol. 9, no. 4, Oct. 2022.